Selected research
Market Structure
Global Globular Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Globular Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Globular Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Globular Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Globular Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Globular Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Globular Protein include CSL, Thermo Fisher Scientific, Merck, Ventria (InVitria), Shire (Baxalta), RAAS, Octapharma, LFB Group and Kedrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Globular Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Globular Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Globular Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Globular Protein market size, projected growth trends, production technologies, key applications, and end-use industries.
Globular Protein Segment by Company
CSL
Thermo Fisher Scientific
Merck
Ventria (InVitria)
Shire (Baxalta)
RAAS
Octapharma
LFB Group
Kedrion
Hualan Bio
Grifols
CBPO
Albumedix
Globular Protein Segment by Type
Recombinant Globular Protein
Human Globular Protein
Bovine Globular Protein
Globular Protein Segment by Application
Therapeutics
Culture Medium Ingredient
Vaccine Ingredient
Other
Globular Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Globular Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Globular Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Globular Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Globular Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Globular Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Globular Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Globular Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant Globular Protein
- Human Globular Protein
- Bovine Globular Protein
Applications
- Therapeutics
- Culture Medium Ingredient
- Vaccine Ingredient
- Other
Companies covered
- CSL
- Thermo Fisher Scientific
- Merck
- Ventria (InVitria)
- Shire (Baxalta)
- RAAS
- Octapharma
- LFB Group
- Kedrion
- Hualan Bio
- Grifols
- CBPO
- Albumedix
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Globular Protein Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Globular Protein Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Globular Protein Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Globular Protein Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Globular Protein Market Dynamics
- 2.1 Globular Protein Industry Trends
- 2.2 Globular Protein Industry Drivers
- 2.3 Globular Protein Industry Opportunities and Challenges
- 2.4 Globular Protein Industry Restraints
3 Globular Protein Market by Manufacturers
- 3.1 Global Globular Protein Revenue by Manufacturers (2021-2026)
- 3.2 Global Globular Protein Sales by Manufacturers (2021-2026)
- 3.3 Global Globular Protein Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Globular Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Globular Protein Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Globular Protein Manufacturers, Product Type & Application
- 3.7 Global Globular Protein Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Globular Protein Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Globular Protein Players Market Share by Revenue in 2025
- 3.8.3 2025 Globular Protein Tier 1, Tier 2, and Tier 3
4 Globular Protein Market by Type
- 4.1 Globular Protein Type Introduction
- 4.1.1 Recombinant Globular Protein
- 4.1.2 Human Globular Protein
- 4.1.3 Bovine Globular Protein
- 4.2 Global Globular Protein Sales by Type
- 4.2.1 Global Globular Protein Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Globular Protein Sales by Type (2021-2032)
- 4.2.3 Global Globular Protein Sales Market Share by Type (2021-2032)
- 4.3 Global Globular Protein Revenue by Type
- 4.3.1 Global Globular Protein Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Globular Protein Revenue by Type (2021-2032)
- 4.3.3 Global Globular Protein Revenue Market Share by Type (2021-2032)
5 Globular Protein Market by Application
- 5.1 Globular Protein Application Introduction
- 5.1.1 Therapeutics
- 5.1.2 Culture Medium Ingredient
- 5.1.3 Vaccine Ingredient
- 5.1.4 Other
- 5.2 Global Globular Protein Sales by Application
- 5.2.1 Global Globular Protein Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Globular Protein Sales by Application (2021-2032)
- 5.2.3 Global Globular Protein Sales Market Share by Application (2021-2032)
- 5.3 Global Globular Protein Revenue by Application
- 5.3.1 Global Globular Protein Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Globular Protein Revenue by Application (2021-2032)
- 5.3.3 Global Globular Protein Revenue Market Share by Application (2021-2032)
6 Global Globular Protein Sales by Region
- 6.1 Global Globular Protein Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Globular Protein Sales by Region (2021-2032)
- 6.2.1 Global Globular Protein Sales by Region (2021-2026)
- 6.2.2 Global Globular Protein Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Globular Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Globular Protein Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Globular Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Globular Protein Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Globular Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Globular Protein Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Globular Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Globular Protein Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Globular Protein Revenue by Region
- 7.1 Global Globular Protein Revenue by Region
- 7.1.1 Global Globular Protein Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Globular Protein Revenue by Region (2021-2026)
- 7.1.3 Global Globular Protein Revenue by Region (2027-2032)
- 7.1.4 Global Globular Protein Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Globular Protein Revenue (2021-2032)
- 7.2.2 North America Globular Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Globular Protein Revenue (2021-2032)
- 7.3.2 Europe Globular Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Globular Protein Revenue (2021-2032)
- 7.4.2 Asia-Pacific Globular Protein Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Globular Protein Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Globular Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CSL
- 8.1.1 CSL Company Information
- 8.1.2 CSL Business Overview
- 8.1.3 CSL Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CSL Globular Protein Product Portfolio
- 8.1.5 CSL Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Globular Protein Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Globular Protein Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Ventria (InVitria)
- 8.4.1 Ventria (InVitria) Company Information
- 8.4.2 Ventria (InVitria) Business Overview
- 8.4.3 Ventria (InVitria) Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Ventria (InVitria) Globular Protein Product Portfolio
- 8.4.5 Ventria (InVitria) Recent Developments
- 8.5 Shire (Baxalta)
- 8.5.1 Shire (Baxalta) Company Information
- 8.5.2 Shire (Baxalta) Business Overview
- 8.5.3 Shire (Baxalta) Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shire (Baxalta) Globular Protein Product Portfolio
- 8.5.5 Shire (Baxalta) Recent Developments
- 8.6 RAAS
- 8.6.1 RAAS Company Information
- 8.6.2 RAAS Business Overview
- 8.6.3 RAAS Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 RAAS Globular Protein Product Portfolio
- 8.6.5 RAAS Recent Developments
- 8.7 Octapharma
- 8.7.1 Octapharma Company Information
- 8.7.2 Octapharma Business Overview
- 8.7.3 Octapharma Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Octapharma Globular Protein Product Portfolio
- 8.7.5 Octapharma Recent Developments
- 8.8 LFB Group
- 8.8.1 LFB Group Company Information
- 8.8.2 LFB Group Business Overview
- 8.8.3 LFB Group Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 LFB Group Globular Protein Product Portfolio
- 8.8.5 LFB Group Recent Developments
- 8.9 Kedrion
- 8.9.1 Kedrion Company Information
- 8.9.2 Kedrion Business Overview
- 8.9.3 Kedrion Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Kedrion Globular Protein Product Portfolio
- 8.9.5 Kedrion Recent Developments
- 8.10 Hualan Bio
- 8.10.1 Hualan Bio Company Information
- 8.10.2 Hualan Bio Business Overview
- 8.10.3 Hualan Bio Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hualan Bio Globular Protein Product Portfolio
- 8.10.5 Hualan Bio Recent Developments
- 8.11 Grifols
- 8.11.1 Grifols Company Information
- 8.11.2 Grifols Business Overview
- 8.11.3 Grifols Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Grifols Globular Protein Product Portfolio
- 8.11.5 Grifols Recent Developments
- 8.12 CBPO
- 8.12.1 CBPO Company Information
- 8.12.2 CBPO Business Overview
- 8.12.3 CBPO Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 CBPO Globular Protein Product Portfolio
- 8.12.5 CBPO Recent Developments
- 8.13 Albumedix
- 8.13.1 Albumedix Company Information
- 8.13.2 Albumedix Business Overview
- 8.13.3 Albumedix Globular Protein Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Albumedix Globular Protein Product Portfolio
- 8.13.5 Albumedix Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Globular Protein Value Chain Analysis
- 9.1.1 Globular Protein Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Globular Protein Production Mode & Process
- 9.2 Globular Protein Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Globular Protein Distributors
- 9.2.3 Globular Protein Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst